Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme

Respiratory Medicine

Volumn 102, Issue 3, 2008, Pages 354-358

  Ferrarotti, I ^a   Gorrini, M ^a   Scabini, R ^a   Ottaviani, S ^a   Mazzola, P ^a   Campo, I ^a   Zorzetto, M ^a   Luisetti, M ^a  

^a Clinica di Malattie dell'Apparato Respiratorio   (Italy)

Author keywords

Alpha1 antitrypsin; COPD; Screening programme

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC BRONCHITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; ITALY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; SCREENING; ADOLESCENT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETICS; MASS SCREENING; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS;

EID: 38849185359     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.10.015     Document Type: Article

References (20)

1. 1-antitrypsin deficiency: molecular pathophysiology. Thorax 59 (2004) 529-535
2. 1-antitrypsin deficiency. Thorax 59 (2004) 164-169
3. 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull WHO 1997;75:397-415.
4. 1-antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
5. Stockley RA, Luisetti M, Miravitlles M, Piituilanen E, Fernandez P on behalf of the Alpha One International Registry (AIR). Ongoing research in Europe: Alpha One International Registry (AIR) objective and development. Eur Respir J 2007;29:582-6.
6. 1-antitrypsin in Italy. Respir Med 93 (1999) 169-172
7. 1-antitrypsin deficiency. J Med Genet 42 (2005) 282-287
8. 1-antitrypsin variants. Diagn Mol Pathol 12 (2004) 160-163
9. 1-antitrypsin in human dried blood spots. Clin Chem 52 (2006) 899-901
10. Global Initiative for Chronic Obstructive Lung Disease. GOLD workshop report update 2004, 2004 〈http://www.goldcopd.com〉.
11. 1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 59 (2004) 843-849
12. Dahl M., Hersh C.P., Ly N.P., Berkey C.S., Silverman E.K., and Nordestgaard B.G. The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 26 (2005) 67-76
13. 1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 20 (1999) 287-291
14. DeMeo D.L., Hersch C.P., Hoffman E.A., et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 176 (2007) 42-48
15. Wood A.M., and Stockley R.A. The genetics of chronic obstructive pulmonary disease. Respir Res 7 (2006) 130
16. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of COPD-2006 update. Am J Respir Crit Care Med 176 (2007) 532-555
17. Travis J., and Salvesen G.S. Human plasma proteinase inhibitors. Annu Rev Biochem 52 (1983) 655-709
18. Pinto-Plata V.M., Mullerova H., Toso J.F., et al. C-reactive protein in patients with COPD, control smokers, and non-smokers. Thorax 61 (2006) 23-28
19. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hensen A., and Nordestgaard B.G. C-reactive protein as predictor of prognosis chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 250-255
20. Seersholm N., Wilcke J.T.R., Kok-Jensen A., and Dirksen A. Risk of hospital admission for obstructive pulmonary disease in α1-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 161 (2000) 81-84